Position in QNCX
as of Mar 31, 2026
· filed May 7, 2026
Position Value
$16,059
-$181,591 QoQ
Shares Held
795
+169.5% QoQ
Ownership
0.005%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#35
of 46 holders
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 0.ToString("F0")%
Shared 0.ToString("F0")%
None 100.ToString("F0")%
Common Shares in QNCX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Parallel Advisors, LLC holds $172,912,509 across 173 Biotechnology names. QNCX ranks #65 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | CORT |
Corcept Therapeutics Inc
|
3,977,404 | $160,329,155 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
5,522 | $2,465,793 | |
| 3 | RCUS |
Arcus Biosciences, Inc.
|
86,557 | $1,869,631 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,107 | $855,312 | |
| 5 | INCY |
Incyte Corp
|
4,919 | $462,976 | |
| 6 | VKTX |
Viking Therapeutics, Inc.
|
14,020 | $456,210 | |
| 7 | KRYS |
Krystal Biotech, Inc.
|
1,688 | $436,044 | |
| 8 | ARGX |
Argenx SE
|
553 | $403,828 |
All Filings in QNCX
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $16,059 | 795 | Shares | Sole | 2026-05-07 | |
| 2025-12-31 | $197,650 | 295 | Shares | Sole | 2026-02-11 | |
| 2025-09-30 | $96,170 | 295 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $97,350 | 295 | Shares | Sole | 2025-07-08 | |
| 2025-03-31 | $78,470 | 295 | Shares | Sole | 2025-04-08 | |
| 2024-12-31 | $110,330 | 295 | Shares | Sole | 2025-02-10 | |
| 2024-09-30 | $45,784 | 295 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $44,250 | 295 | Shares | Sole | 2024-08-08 | |
| 2024-03-31 | $65,932 | 311 | Shares | Sole | 2024-05-06 | |
| 2023-12-31 | $498,960 | 2,376 | Shares | Sole | 2024-02-12 | |
| 2023-09-30 | $532,224 | 2,376 | Shares | Sole | 2024-05-20 | |
| 2023-06-30 | $715,176 | 2,376 | Shares | Sole | 2024-05-20 | |
| 2023-03-31 | $741,312 | 2,376 | Shares | Sole | 2024-05-20 | |
| 2022-12-31 | $310,983 | 2,441 | Shares | Sole | 2023-02-06 | |
| 2022-09-30 | $649,306 | 2,441 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $1,083,804 | 2,441 | Shares | Sole | 2022-08-01 | |
| 2022-03-31 | $1,918,900 | 1,550 | Shares | Sole | 2022-04-28 | |
| 2021-12-31 | $4,104,024 | 1,626 | Shares | Sole | 2022-01-20 | |
| 2021-09-30 | $39,230,480 | 2,140 | Shares | Sole | 2021-11-02 | |
| 2021-06-30 | $13,101,600 | 1,236 | Shares | Sole | 2021-08-06 | |
| 2021-03-31 | $6,824,082 | 947 | Shares | Sole | 2021-04-23 | |
| 2020-12-31 | $5,261,532 | 947 | Shares | Sole | 2021-02-02 | |
| 2020-09-30 | $9,470,000 | 947 | Shares | Sole | 2020-10-27 | |
| 2020-06-30 | $8,769,220 | 947 | Shares | Sole | 2020-07-16 | |
| 2020-03-31 | $8,638,534 | 947 | Shares | Sole | 2020-04-27 | |
| No filing history on record for this holder in this stock. | ||||||